Results 101 to 110 of about 3,638 (152)

A phase 4, open-label, multicenter study of the safety and efficacy of agalsidase beta in Chinese patients with Fabry disease. [PDF]

open access: yesOrphanet J Rare Dis
Ren H   +14 more
europepmc   +1 more source

Dapagliflozin in Patients With CKD With Fabry Disease. [PDF]

open access: yesKidney Int Rep
Battaglia Y   +21 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy